Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
This early adjustment period is important because it helps distinguish expected side effects from symptoms that may require medical review
Wegovy 2.4mg FlexTouch By Novo Nordisk India Pvt Ltd All prices are inclusive of taxes Dosage 2.4mg Pack Size 1 Pen of 3ml Active Ingredient/Salt Semaglutide Product Description Wegovy 2.4 mg FlexTouch contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for chronic weight management in adults who are overweight or obese, and for reducing the risk of major cardiovascular events such as heart attack or stroke in adults with established heart disease and excess weight
At Universal Weight Loss Clinic, we are committed to offering the latest and most effective treatments to support your weight loss journey
Side Effects and Safety Considerations for Each Option Injectable GLP-1 receptor agonists most commonly cause nausea and gastrointestinal symptoms
Yet, while their ability to reduce body weight and insulin levels was greater than GLP1 monotherapy in male models 33,34,35 , the potential of these GLP1-based multi-agonists for the treatment of the metabolic, hormonal, and gonadal complications associated with PCOS has not been explored to date
